VIRAL LOAD MONITORING – HEPATITIS C VIRUS (HCV) - ANVISA Registration 10322250060

Access comprehensive regulatory information for VIRAL LOAD MONITORING – HEPATITIS C VIRUS (HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10322250060 and manufactured by QIAGEN GMBH. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until Sep 28, 2025.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 4 companies making the same product including ABBOTT MOLECULAR INC, ROCHE MOLECULAR SYSTEMS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.